Literature DB >> 17916438

[Abruptio placentae. Management in a reference Nigerien maternity. Prospective study about 118 cases during one year].

M Nayama1, D Tamakloé-Azamesu, M Garba, N Idi, B Djibril, M Kamayé, A Marafa, A Touré, F Z Diallo, V Houfflin-Debarge.   

Abstract

OBJECTIVE: Placental abruption is a syndrome, which occurs in the third trimester of the pregnancy or during labour. It is the main cause of pregnancy last term bleeding and is also responsible for a high stillbirth rate. The objective is to describe the epidemiological, clinical, paraclinical and therapeutic characteristics in order to decrease the fetal and maternal mortality and morbidity. PATIENTS AND METHODS: It is a prospective and descriptive study in continuous series, over a twelve-month period, from 1st January 2003 to 31st December 2003, at Issaka Gazobi maternity of Niamey, Niger.
RESULTS: During the study period, 3255 deliveries have been done. One hundred and eighteen placental abruptions have been observed, which corresponds to a frequency of 3.6% with the highest rate during raining season. The average age and parity were: 31 years and 5th with a predominance of grand multiparous (38.2%). The majority of the patients were in-utero transfers (83,1%) and had done at least 10 km before arriving. One hundred and eleven patients had a caesarean section (94,1%) and 7 delivered through the vaginal route (5.9%). The fetal prognosis was characterized by a high stillbirth rate of 71.3% (87/122), fetal hypotrophy (64.8%) and prematurity (23.8%). The main cause of maternal morbidity was anaemia (76.3%) and Disseminated Intravascular Coagulation (5.9%). Further, 81 patients have been transfused (68.7%). The maternal mortality was 5.1% (6/118). DISCUSSION AND
CONCLUSION: Placental abruption, a medical and obstetrical emergency, is a serious obstetric condition, especially in our country. Physicians must be aware that patients with high blood pressure, preeclampsia, eclampsia, particularly in case of multiparity are at increased risk of placental abruption. Early diagnosis, prenatal follow-up and caesarean section improve the maternal and fetal prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 17916438     DOI: 10.1016/j.gyobfe.2007.05.023

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  6 in total

1.  Maternal hemoglobin level and fetal outcome at low and high altitudes.

Authors:  Gustavo F Gonzales; Kyle Steenland; Vilma Tapia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-09       Impact factor: 3.619

2.  Antepartum Hemorrhage: A Retrospective Analysis from a Northern Nigerian Teaching Hospital.

Authors:  Idris Usman Takai; Badia Maje Sayyadi; Hadiza Shehu Galadanci
Journal:  Int J Appl Basic Med Res       Date:  2017 Apr-Jun

3.  Diagnosis and Management of Pregnant Women With Placental Abruption and Neonatal Outcomes.

Authors:  Souhail Alouini; Antoine Valery; Bruno Lemaire; Marie-Liesse Evrard; Olivier Belin
Journal:  Cureus       Date:  2022-01-11

4.  Frequency, risk factors and feto-maternal outcomes of abruptio placentae in Northern Tanzania: a registry-based retrospective cohort study.

Authors:  Godwin S Macheku; Rune Nathaniel Philemon; Olola Oneko; Pendo S Mlay; Gileard Masenga; Joseph Obure; Michael Johnson Mahande
Journal:  BMC Pregnancy Childbirth       Date:  2015-10-07       Impact factor: 3.007

5.  [Epidemiological, prognostic and therapeutic aspects of retro placental hematoma (HRP) in a referral maternity in rural area].

Authors:  Ousmane Thiam; Magatte Mbaye; Abdou Aziz Diouf; Fode Baba Touré; Mamour Gueye; Mansour Niang; Mamadou Lamine Cissé; Sidy Dièye; Jean Charles Moreau
Journal:  Pan Afr Med J       Date:  2014-01-14

Review 6.  Interactions between the Physical and Social Environments with Adverse Pregnancy Events Related to Placental Disorders-A Scoping Review.

Authors:  Yolisa Prudence Dube; Newton Nyapwere; Laura A Magee; Marianne Vidler; Sophie E Moore; Benjamin Barratt; Rachel Craik; Peter von Dadelszen; Prestige Tatenda Makanga
Journal:  Int J Environ Res Public Health       Date:  2020-07-28       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.